Diane Bowen, MD
Plastic and Reconstructive Surgery · Saint Simons Island, GANPI 1215950431
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $2,700 of the $3,752 with a category attached, or 72.0%. AbbVie accounts for 91.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $2,813 and has fallen 94.0% since, to $170 in 2025.
Across 40 payments — averaging $93.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Mentor Worldwide LLC$155
- Acelrx Pharmaceuticals, Inc.$34
- Henry Schein, Inc.$34
- TELA Bio, Inc.$27
- Smith+Nephew$24
- plus $44 from 2 others
What the payments were for
- Food & beverage$1,05228%
- Gifts$2,70072%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $3,433 |
| Mentor Worldwide LLC | 5 | $155 |
| Acelrx Pharmaceuticals, Inc. | 2 | $34 |
| Henry Schein, Inc. | 1 | $34 |
| TELA Bio, Inc. | 1 | $27 |
| Smith+Nephew | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,752 in reported general payments places this provider in the 60th percentile of 83 plastic and reconstructive surgery providers in Georgia.
See all plastic and reconstructive surgery providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 17 | $29 |
| Tramadol Hcl | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Saint Simons Island
- Rajiv SoodAugusta$502K
- Carmen KavaliAtlanta$233K
- Randal RuddermanAlpharetta$207K
- James NamnoumAtlanta$97K
- Michael MirzabeigiAtlanta$71K
- Katherine SantosaAtlanta$65K
- Marc YuneRoswell$64K
- Asaf YalifAlpharetta$43K
- Luther BakerColquitt$40K
- Olumayowa AbiodunAlbany$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.